The metal-binding properties of DREAM - Evidence for calcium-mediated changes in DREAM structure

被引:38
作者
Craig, TA
Benson, LM
Venyaminov, SY
Klimtchuk, ES
Bajzer, Z
Prendergast, FG
Naylor, S
Kumar, R
机构
[1] Mayo Clin & Mayo Fdn, Dept Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Biomed Mass Spectrometry & Funct Proteom Facil, Rochester, MN 55905 USA
关键词
D O I
10.1074/jbc.M109660200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DREAM, an EF-hand protein, associates with and modulates the activity of presenilins and Kv4 potassium channels in neural and cardiac tissues and represses prodynorphin and c-fos gene expression by binding to DNA response elements in these genes. Information concerning the metal-binding properties of DREAM and the consequences of metal binding on protein structure are important in understanding how this protein functions in cells. We now show that DREAM binds 1 mol of calcium/mol of protein with relatively high affinity and another 3 mol of calcium with lower affinity. DREAM binds 1 mol of magnesium/mol of protein. DREAM, pre-loaded with 1 mol of calcium, binds 1 mol of magnesium, thus demonstrating that the magnesium-binding site is distinct from the high affinity calcium-binding site. Analysis of metal binding to mutant DREAM protein constructs localizes the high affinity calcium-binding site and the magnesium-binding site to EF-hands 3 or 4. Binding of calcium but not magnesium changes the con. formation, stability, and a-helical content of DREAM. Calcium, but not magnesium, reduces the affinity of apo-DREAM for specific DNA response elements in the pro. dynorphin and c-fos genes. We conclude that DREAM binds calcium and magnesium and that calcium, but not magnesium, modulates DREAM structure and function.
引用
收藏
页码:10955 / 10966
页数:12
相关论文
共 60 条
[11]   Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [J].
Citron, M ;
Westaway, D ;
Xia, WM ;
Carlson, G ;
Diehl, T ;
Levesque, G ;
JohnsonWood, K ;
Lee, M ;
Seubert, P ;
Davis, A ;
Kholodenko, D ;
Motter, R ;
Sherrington, R ;
Perry, B ;
Yao, H ;
Strome, R ;
Lieberburg, I ;
Rommens, J ;
Kim, S ;
Schenk, D ;
Fraser, P ;
Hyslop, PS ;
Selkoe, DJ .
NATURE MEDICINE, 1997, 3 (01) :67-72
[12]   Factors influencing the processing and function of the amyloid β precursor protein -: a potential therapeutic target in Alzheimer's disease? [J].
Coughlan, CM ;
Breen, KC .
PHARMACOLOGY & THERAPEUTICS, 2000, 86 (02) :111-144
[13]   Zinc binding properties of the DNA binding: Domain of the 1,25-dihydroxyvitamin D-3 receptor [J].
Craig, TA ;
Veenstra, TD ;
Naylor, S ;
Tomlinson, AJ ;
Johnson, KL ;
Macura, S ;
Juranic, N ;
Kumar, R .
BIOCHEMISTRY, 1997, 36 (34) :10482-10491
[14]   Synthesis and purification of soluble ligand binding domain of the human vitamin D-3 receptor [J].
Craig, TA ;
Kumar, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (03) :902-907
[15]   Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms [J].
Czech, C ;
Tremp, G ;
Pradier, L .
PROGRESS IN NEUROBIOLOGY, 2000, 60 (04) :363-384
[16]   Purification of myristoylated and nonmyristoylated neuronal calcium sensor-1 using single-step hydrophobic interaction chromatography [J].
Fisher, JR ;
Sharma, Y ;
Iuliano, S ;
Piccioti, RA ;
Krylov, D ;
Hurley, J ;
Roder, J ;
Jeromin, A .
PROTEIN EXPRESSION AND PURIFICATION, 2000, 20 (01) :66-72
[17]  
GROSS MD, 1987, J BIOL CHEM, V262, P6539
[18]  
HARDING GE, 2001, NAT NEUROSCI, V4, P2651
[19]  
HEWICK RM, 1981, J BIOL CHEM, V256, P7990
[20]  
Innis MA., 1990, PCR PROTOCOLS, P3